Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.
Take action
Contact the company
📍Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer
Hospira Inc. is recalling 603,768 bags of 0.9% Sodium Chloride Injection, USP (1000 mL flexible container) because the solution may leak through the port cover of the primary container. This defect was identified during a retain sample visual inspection and raises concerns about the assurance of sterility for these medical supplies. The recall affects units distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/46261-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-1000.
“Hospira Recalls Sodium Chloride Injection Due to Sterility Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46261-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-1000. Based on FDA recall #D-1096-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1096-2014%22&limit=1).
The FDA announced on Feb. 11, 2014, that Hospira Inc. voluntarily recalled 603,768 bags of 0.9% Sodium Chloride Injection due to a lack of sterility assurance caused by solution leaking through the port cover. The recall was classified as Class II and has since been terminated.
How to tell if you have it
Brand: Hospira
Product: 0.9% Sodium Chloride Injection, USP 1000 mL Flexible Container
NDC: 0409-7983-09
Lot code: 34-609-FW
Expiration date: 10/15
Quantity: 603,768 bags
The hazard
The hazard stems from a lack of assurance of sterility because the solution was leaking through the port cover of the primary container. This defect was identified during a retain sample visual inspection.
Context
GovInfoNow's records show Hospira Inc. has had 108 other recalls on record since April 5, 2012. Other recent recalls include a 2017-04-21 recall for hair particulates in syringes and a 2016-11-01 recall for broken ampule tips risking infection. Additional similar product recalls by Fresenius Kabi regarding lack of sterility assurance occurred on March 11, 2026.
How to tell if you have this one
Look for 0.9% Sodium Chloride Injection, USP in a 1000 mL flexible container manufactured by Hospira Inc. Specifically check for NDC 0409-7983-09 and Lot number 34-609-FW with an expiration date of 10/15.
Brand
Hospira
Category
Drug
Based on the official FDA remedy
What to do — step by step
Identify Affected Product
Check your inventory for Hospira 0.9% Sodium Chloride Injection, USP, NDC 0409-7983-09, Lot 34-609-FW, Exp 10/15.
Contact Manufacturer
The record does not specify a remedy or return process; contact Hospira Inc. in Lake Forest, IL for further instructions.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1096-2014 (February 11, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1096-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.